BR9711882A - Fragmento, variante ou fragmento de variante de polipeptídeo de acetilidrolase (paf-ah), polinucleotídeo isolado, vetor de dna, célula hospedeira transformada ou transfectada com um dna, processo para a produção de um fragmento, variante ou fragmento de variante de polipeptídeo de paf - ah de plasma, composição farmacêutica, e, processo para tratar um mamífero suscetível a, ou sofrendo de, um quadro patológico mediado por paf. - Google Patents
Fragmento, variante ou fragmento de variante de polipeptídeo de acetilidrolase (paf-ah), polinucleotídeo isolado, vetor de dna, célula hospedeira transformada ou transfectada com um dna, processo para a produção de um fragmento, variante ou fragmento de variante de polipeptídeo de paf - ah de plasma, composição farmacêutica, e, processo para tratar um mamífero suscetível a, ou sofrendo de, um quadro patológico mediado por paf.Info
- Publication number
- BR9711882A BR9711882A BR9711882-6A BR9711882A BR9711882A BR 9711882 A BR9711882 A BR 9711882A BR 9711882 A BR9711882 A BR 9711882A BR 9711882 A BR9711882 A BR 9711882A
- Authority
- BR
- Brazil
- Prior art keywords
- fragment
- paf
- variant
- polypeptide
- dna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01047—1-Alkyl-2-acetylglycerophosphocholine esterase (3.1.1.47), i.e. platelet-activating factor acetylhydrolase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Otolaryngology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
"FRAGMENTO, VARIANTE OU FRAGMENTO DE VARIANTE DE POLIPEPTìDEO DE ACETILIDROLASE (PAF-AH), POLINUCLEOTìDEO ISOLADO, VETOR DE DNA, CéLULA HOSPEDEIRA TRANSFORMADA OU TRANSFECTADA COM UM DNA, PROCESSO PARA A PRODUçãO DE UM FRAGMENTO, VARIANTE OU FRAGMENTO DE VARIANTE DE POLIPEPTìDEO DE PAF-AH DO PAF-AH DE PLASMA, COMPOSIçãO FARMACêUTICA, E, PROCESSO PARA TRATAR UM MAMìFERO SUSCETìVEL A, OU SOFRENDO DE, UM QUADRO PATALóGICO MEDIADO POR PAF". A presente invenção proporciona seq³ências de polinucleotídeos purificadas e isoladas codificantes do fator ativador de plaquetas do plasma humano, acetilidrolase. Também se proporciona materiais e processos para a produção recombinante de produtos de fator ativador de plaquetas, acetilidrolase, que se espera seja úteis na regulação de eventos inflamatórios patológicos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1997/014212 WO1999009147A1 (en) | 1997-08-13 | 1997-08-13 | Truncated platelet-activating factor acetylhydrolase |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9711882A true BR9711882A (pt) | 1999-09-21 |
Family
ID=22261441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9711882-6A BR9711882A (pt) | 1997-08-13 | 1997-08-13 | Fragmento, variante ou fragmento de variante de polipeptídeo de acetilidrolase (paf-ah), polinucleotídeo isolado, vetor de dna, célula hospedeira transformada ou transfectada com um dna, processo para a produção de um fragmento, variante ou fragmento de variante de polipeptídeo de paf - ah de plasma, composição farmacêutica, e, processo para tratar um mamífero suscetível a, ou sofrendo de, um quadro patológico mediado por paf. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0948605A1 (pt) |
JP (1) | JP2001502163A (pt) |
AU (1) | AU751594B2 (pt) |
BR (1) | BR9711882A (pt) |
CA (1) | CA2267994C (pt) |
CZ (1) | CZ297603B6 (pt) |
HU (1) | HUP9903959A3 (pt) |
IL (3) | IL129262A0 (pt) |
NO (1) | NO326968B1 (pt) |
PL (1) | PL190532B1 (pt) |
SK (1) | SK286518B6 (pt) |
WO (1) | WO1999009147A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5981252A (en) | 1993-06-25 | 1999-11-09 | Smithkline Beecham | Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
EP1294943A2 (en) * | 2000-01-20 | 2003-03-26 | Genome Therapeutics Corporation | RAPID DETERMINATION OF GENE STRUCTURE USING cDNA SEQUENCE |
CN103891709A (zh) * | 2012-12-24 | 2014-07-02 | 深圳先进技术研究院 | 细胞冻存液及细胞冻存方法 |
CN112575057B (zh) * | 2020-12-11 | 2021-07-30 | 深圳上泰生物工程有限公司 | 一种组合物及其在检测脂蛋白相关磷脂酶a2活性中的应用 |
WO2022120784A1 (zh) * | 2020-12-11 | 2022-06-16 | 深圳上泰生物工程有限公司 | 一种组合物及其在检测脂蛋白相关磷脂酶a2活性中的应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5981252A (en) * | 1993-06-25 | 1999-11-09 | Smithkline Beecham | Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
PT673426E (pt) * | 1993-10-06 | 2001-11-30 | Icos Corp | Acetil-hidrolase do factor activador das plaquetas |
EP0853673A1 (en) * | 1995-09-29 | 1998-07-22 | Smithkline Beecham Plc | COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
JP2002515728A (ja) * | 1995-09-29 | 2002-05-28 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 新規用途 |
-
1997
- 1997-08-13 WO PCT/US1997/014212 patent/WO1999009147A1/en active IP Right Grant
- 1997-08-13 CZ CZ0124199A patent/CZ297603B6/cs not_active IP Right Cessation
- 1997-08-13 BR BR9711882-6A patent/BR9711882A/pt not_active Application Discontinuation
- 1997-08-13 JP JP10509976A patent/JP2001502163A/ja active Pending
- 1997-08-13 CA CA002267994A patent/CA2267994C/en not_active Expired - Lifetime
- 1997-08-13 AU AU39782/97A patent/AU751594B2/en not_active Expired
- 1997-08-13 EP EP97937217A patent/EP0948605A1/en not_active Withdrawn
- 1997-08-13 SK SK473-99A patent/SK286518B6/sk not_active IP Right Cessation
- 1997-08-13 PL PL97332833A patent/PL190532B1/pl unknown
- 1997-08-13 HU HU9903959A patent/HUP9903959A3/hu unknown
- 1997-08-13 IL IL12926297A patent/IL129262A0/xx active IP Right Grant
-
1999
- 1999-03-30 IL IL129262A patent/IL129262A/en not_active IP Right Cessation
- 1999-04-12 NO NO19991717A patent/NO326968B1/no not_active IP Right Cessation
-
2006
- 2006-02-21 IL IL173867A patent/IL173867A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU3978297A (en) | 1999-03-08 |
PL190532B1 (pl) | 2005-12-30 |
CA2267994C (en) | 2005-04-12 |
JP2001502163A (ja) | 2001-02-20 |
IL173867A0 (en) | 2006-07-05 |
SK286518B6 (sk) | 2008-12-05 |
AU751594B2 (en) | 2002-08-22 |
WO1999009147A1 (en) | 1999-02-25 |
HUP9903959A3 (en) | 2002-01-28 |
EP0948605A1 (en) | 1999-10-13 |
CZ124199A3 (cs) | 2000-06-14 |
PL332833A1 (en) | 1999-10-11 |
NO991717D0 (no) | 1999-04-12 |
CA2267994A1 (en) | 1999-02-25 |
NO326968B1 (no) | 2009-03-23 |
IL129262A0 (en) | 2000-02-17 |
HUP9903959A2 (hu) | 2000-03-28 |
IL129262A (en) | 2006-06-11 |
NO991717L (no) | 1999-06-11 |
SK47399A3 (en) | 2000-11-07 |
CZ297603B6 (cs) | 2007-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Molino et al. | Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G | |
BR0309576A (pt) | Variante de polipeptìdeo do fator vii (fvii) ou fator viia (fviia), sequência de nucleotìdeo, vetor de expressão, célula hospedeira, composição farmacêutica, uso de uma variante, e, método para tratar um mamìfero que tenha uma doença ou um distúrbio em que a formação de coágulo é desejável | |
GB2364059A (en) | Beta-Secretase enzyme compositions and methods | |
DE69427392T2 (de) | Acethylhydrolase des plättchen aktivierenden faktors | |
BRPI9909018B8 (pt) | processo para a síntese de um peptídeo | |
ATE199099T1 (de) | Verfahren und zusammensetzungen für die gen therapie zur behandlung von fehlern im lipoproteinmetalbolismus | |
HUP0300067A2 (en) | Novel method for down-regulation of amyloid | |
Hung et al. | Structure and anticancer activity of a new lectin from the cultivated red alga, Kappaphycus striatus | |
BR0312913A (pt) | Ativo de biciclo-pirazóis como inibidores de cinase, processo para sua preparação e composições farmacêuticas compreendendo o mesmo | |
Eble et al. | Vipera lebetina venom contains two disintegrins inhibiting laminin-binding β1 integrins | |
MY103943A (en) | Orthorhombic ciclosporin crystal form, process for its production and pharmaceutical compositions containing it | |
Calvete et al. | The disulphide bond pattern of bitistatin, a disintegrin isolated from the venom of the viper Bitis arietans | |
IT1265101B1 (it) | Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico | |
BR9508714A (pt) | Composto processo de preparação de estreptogramas por muta-síntese sequencia nucleotídica dna recombinante vetor utilização de uma sequencia e/ou de um vetor polipetídeo cepa mutante e composição farmacèutica | |
Zushi et al. | Aspartic acid 349 in the fourth epidermal growth factor-like structure of human thrombomodulin plays a role in its Ca (2+)-mediated binding to protein C. | |
BR9711882A (pt) | Fragmento, variante ou fragmento de variante de polipeptídeo de acetilidrolase (paf-ah), polinucleotídeo isolado, vetor de dna, célula hospedeira transformada ou transfectada com um dna, processo para a produção de um fragmento, variante ou fragmento de variante de polipeptídeo de paf - ah de plasma, composição farmacêutica, e, processo para tratar um mamífero suscetível a, ou sofrendo de, um quadro patológico mediado por paf. | |
BR9609041A (pt) | "terapia de substituição para cáries dentais". | |
Gasmi et al. | Amino acid structure and characterization of a heterodimeric disintegrin from Vipera lebetina venom | |
AU4893199A (en) | Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof | |
Gomes et al. | Hannahpep: a novel fibrinolytic peptide from the Indian King Cobra (Ophiophagus hannah) venom | |
HUP0101715A2 (hu) | Eljárások és készítmények reumatoid artritisz kezelésére | |
Chernyshenko et al. | Fibrin (ogen) olytic and platelet modulating activity of a novel protease from the Echis multisquamatis snake venom | |
Soares et al. | Mn2+ ions reduce the enzymatic and pharmacological activities of bothropstoxin-I, a myotoxic Lys49 phospholipase A2 homologue from Bothrops jararacussu snake venom | |
Tsai et al. | Comparative proteomics and subtyping of venom phospholipases A2 and disintegrins of Protobothrops pit vipers | |
BR9911511A (pt) | Vetor de propionibacterium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |